Sesamol, a substance found in sesame, can act like a weak estrogen in breast cancer cells, but it's much weaker than the real estrogen hormone.

Based on our analysis of the available research, the evidence we've reviewed so far leans toward sesamol having weak estrogenic activity in human breast cancer cells. We examined one claim, supported by four studies, with no studies we've found that refute it [1]. Specifically, the evidence indicates that sesamol, a compound found in sesame, can act like a weak estrogen in breast cancer cells, but it is much weaker than the natural estrogen hormone [1]. This means that while sesamol does appear to interact with estrogen receptors in these cells, its effect is not as strong as the body's own estrogen. We want to be clear that this is our current analysis based on the studies we have looked at. With only one claim and four supporting studies, the evidence is limited but consistent. We have not seen contradictory findings so far, but more research could change our understanding. The term "estrogenic activity" simply means the substance can mimic some effects of estrogen, and here the effect is described as weak. For someone reading this, the practical takeaway is that sesamol might have a mild estrogen-like effect in a lab setting, but because it is much weaker than real estrogen, it is not likely to act like a strong hormone in the body. If you are concerned about estrogenic compounds, this is something to keep in mind, but the evidence does not suggest sesamol is a major player compared to natural estrogen. As always, we base our conclusions only on the evidence we have reviewed so far.